Emergent BioSolutions

Emergent BioSolutions is a large biotechnology company headquartered in Gaithersburg, Maryland. Employing over 1429 people, the company generates approximately $1 billion in annual revenue. Emergent BioSolutions is dedicated to developing, manufacturing, and distributing solutions to safeguard public health from potential threats. At the core of Emergent's mission is the creation of products and services designed to mitigate risks associated with public health crises. Their work encompasses a wide range of areas, including the development of vaccines, antidotes, and other therapeutic interventions. These solutions are intended to protect individuals and communities from a variety of potential threats, ensuring preparedness in the face of unforeseen events. Emergent BioSolutions distinguishes itself through its commitment to innovation and its unwavering focus on public health security. The company invests heavily in research and development, constantly striving to advance the science and technology behind its products. For further information or inquiries, please visit Emergent BioSolutions' website at emergentbiosolutions.com.